Loading...

477 posters, 14 topics, 2,065 authors, 1,055 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The Joint EBJIS-MSIS 2026 Conference

17 - 19 September, 2026 | Porto, Portugal

The Joint EBJIS-MSIS 2026 Conference banner

PP51

Double DAIR for Acute-PJI: Positive Culture at Second Stage Increases the Risk of Subsequent Failure

Part of Topic

Prosthetic Joint Infections

Double DAIR for Acute-PJI: Positive Culture at Second Stage Increases the Risk of Subsequent Failure

M. Lane Moore, MD, MBA; Collin L. Braithwaite, MD; Saad Tarabichi, MD; Jens T. Verhey, MD; Henry D. Clarke, MD; Joshua S. Bingham, MD; Mark J. Spangehl, MD
Mayo Clinic Arizona Department of Orthopedic Surgery

 

BACKGROUND

•Debridement, antibiotics, and implant retention (DAIR) is commonly used in the management of acute periprosthetic joint infection (PJI) when implant retention is considered feasible. More recently, the double-DAIR technique has gained increasing attention as a strategy for acute PJI.
•An unknown is how frequently cultures remain positive at the second stage and whether persistent culture positivity represents clinically meaningful residual infection or predicts subsequent treatment failure. Understanding the prognostic significance of second-stage cultures could help identify patients at increased risk for recurrent infection and potentially guide postoperative management
•Purpose: To determine the rate of culture positivity at the second debridement and evaluate whether ≥1 positive intraoperative culture at the second stage is associated with worse clinical outcomes following double DAIR.

METHODS

•Retrospective review of all patients who underwent a double-DAIR protocol for acute PJI at a single institution.
•Acute PJI was defined as infection occurring <28 days from the index arthroplasty or symptom onset. PJI was defined according to the 2013 MSIS criteria
•All patients had a minimum of 1 year of follow-up.
•Treatment failure was defined as:
•Any reoperation for infection at latest follow-up, or
•Mortality within 1 year following surgery.
•Multivariable logistic regression controlled for: Patient demographics, history of failed surgical treatment for PJI, and organism virulence

The primary exposure was ≥1 positive intraoperative culture at the second debridement

 

RESULTS

•A total of 131 patients were included:
•71 knees
•60 hips
•Of these, 15 patients (11.5%) had ≥1 positive culture at the second debridement.
•Patients with a positive culture at the second stage demonstrated more than double the observed rate of treatment failure compared with those whose cultures were negative.
•On multivariable regression analysis, ≥1 positive culture at second debridement was an independent risk factor for subsequent reoperation:
•Adjusted OR 4.9
•95% CI: 1.3–18.4; p=0.015

CONCLUSION

•Persistent culture positivity at the second debridement was relatively uncommon, occurring in approximately 1 in 9 patients undergoing double DAIR; however, when present, it was strongly associated with worse clinical outcomes.
•Patients with ≥1 positive second-stage culture experienced a 40.0% treatment-failure rate compared with 18.1% among those with negative cultures. After adjustment for relevant clinical factors, second-stage culture positivity remained an independent predictor of reoperation, with nearly five-fold greater odds of subsequent reoperation.
•These findings suggest that microbiologic results from the second debridement provide important prognostic information following double DAIR. Patients with persistent positive cultures may represent a higher-risk subgroup in whom standard postoperative management may be insufficient.
ebjis-msis2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.